Palisade Bio Inc.
PALI | NASDAQ
$1.64
-$0.05 (-2.96%)
Sep 22, 2026, 2:07 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -7.83 | -0.16 | -0.33 | -4.72 | -0.45 | -21.29 |
PEG Ratio | 0.08 | 0 | -0.01 | 0.05 | 0 | -0.02 |
PS Ratio | n/a | n/a | 16.14 | n/a | n/a | n/a |
PB Ratio | 1.01 | 0.31 | 0.36 | 5.50 | 1.64 | -464.27 |
P/FCF Ratio | -12.06 | -0.19 | -0.36 | -5.13 | -0.82 | -690.37 |
P/OCF Ratio | -12.06 | -0.19 | -0.36 | -5.14 | -0.82 | -691.24 |
OCF/S Ratio | n/a | n/a | -4.45K | n/a | n/a | n/a |
Debt / Equity Ratio | 0 | 0.02 | 0.03 | 0.03 | 0.03 | -0.20 |
Quick Ratio | 28.95 | 3.24 | 5.15 | 4.89 | 4.61 | 0.11 |
Current Ratio | 28.95 | 3.24 | 5.15 | 4.89 | 4.61 | 0.11 |
Asset Turnover | n/a | n/a | 0.02 | n/a | n/a | n/a |
Interest Coverage | -1.81K | -1.24K | -871.33 | -1.21K | -17.45 | -39.56 |
Return on Equity | -12.97% | -192.71% | -108.72% | -114.27% | -361.38% | 145.40% |
Return on Assets | -12.49% | -132.70% | -87.53% | -90.47% | -212.72% | -341.90% |
Return on Invested Capital | -13.91% | -190.82% | -111.28% | -121.45% | -409.73% | 241.61% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 100% | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | -4.92K% | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | -4.92K% | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | -5.23K% | n/a | n/a | n/a |
FCF Margin | n/a | n/a | -4.45K% | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | -4.91K% | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove PALI